close

Enter

Log in using OpenID

Outsourced-Drug-Discovery-Market1-

embedDownload
Outsourced Drug Discovery Market Shows
Expected Growth from 2019-2026
Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and Large
Molecule Drugs), by Services (Preclinical Developments, Target validation and
Functional Informatics, Target Identification and Screening, Lead Identification and
Candidate Optimization, and Others), by Application (Oncology, Ophthalmology,
Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology,
Cardiology, and Others), by End Users (Pharmaceutical and Biotechnological
Companies, Contract research Organization, and Contract Manufacturing
Organization), by Region (North America, Latin America, Europe, Asia Pacific, Middle
East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026
Outsourced drug discovery is a contract-based process, which is conducted by the contract research
organizations (CRO) and contract manufacturing organization (CMO). Contract research organization
provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery
and development. CRO facilitates the various services such as biopharmaceutical development,
biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug
discovery and development.
Market Dynamics
New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth
of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a
British drug manufacturing company collaborated with the University of California to establish a stateof-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San
Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop
new technologies using CRISPR to rapidly accelerate the discovery of new medicines.
Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery
market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership
with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its
longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory
program is related to the preclinical drug development for treatment of respiratory diseases and rare
diseases.
Increasing number of drug discovery companies is expected to drive growth of the global
outsourced drug discovery market
Increasing number of new drug discovery companies is expected to drive the global outsourced drug
discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi
AppTec and launched new drug discovery company, Faxian Therapeutics (Headquarter– New York,
U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s drug
design and synthesis services to improve health care needs.
Ask For a Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/2847
Moreover, rising drug discovery services is expected to propel growth of global outsourced drug
discovery market. For instance, in April 2019, Eurofins Discovery Services, a contract research
organization, launched new drug discovery service DiscoveryOne. The new approach is helpful for the
drug discovery research activities and preclinical developments. Hence, launching of services related
to drug discovery is expected to support the global outsourced drug discovery market growth.
Global Outsourced Drug Discovery Market - Competitive Landscape
Key players operating in the global outsourced drug discovery market are Aurigene Accelerating
Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec
AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia
Meditech Co. Ltd.
Global Outsourced Drug Discovery Market- Regional Analysis
North America outsourced drug discovery market is expected to account for the largest market share,
owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic
Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With
this acquisition, Lambda Therapeutic Research entered into the U.S. market.
Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buynow/2847
Detailed Segmentation:




Global Outsourced Drug Discovery Market, By Drug Type:
o Small Molecule Drugs
o Large Molecule Drugs
Global Outsourced Drug Discovery market, By Services:
o Preclinical Development
o Target Validation and Functional Informatics
o Target Identification and Screening
o Lead Identification and Candidate Optimization
o Others
Global Outsourced Drug Discovery Market, By Application
o Oncology
o Ophthalmology
o Hematology
o Immunomodulation
o Anti-Infective Drugs
o Dermatology
o Pulmonology
o Cardiology
o Others
Global Outsourced Drug Discovery market, By End User
o Pharmaceutical and Biotechnological Companies
o Contract Research Organization
o Contract Manufacturing Organization
Moreover, Europe is also projected to witness significant growth in the global outsourced drug discovery
market, owing to increasing merger and acquisition activities by key players in the region. For instance,
in February 2019, Optimapharm, a clinical research organization (CRO) in Europe acquired Denothex,
a CRO, for strengthening its presence in the European market particularly in France, Spain,
Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe and Israel.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran303   documents Email
Document
Category
Uncategorized
Views
0
File Size
319 KB
Tags
outsourced, drugs, market, discovery
1/--pages
Report inappropriate content